Article thumbnail

Expression of Osteopontin in oesophageal squamous cell carcinoma

By Y Kita, S Natsugoe, H Okumura, M Matsumoto, Y Uchikado, T Setoyama, T Owaki, S Ishigami and T Aikou

Abstract

Osteopontin is a multifunctional 34 kDa extracellular matrix protein with a cell-binding domain. It is involved cell adhesion and cell migration and is therefore considered to influence tumorigenesis and/or metastasis. The purpose of the present study was to evaluate the clinical significance of Osteopontin expression in oesophageal squamous cell carcinoma (ESCC). In the present study, we immunohistochemically investigated the relationship between Osteopontin expression and clinicopathological factors including prognosis in surgical specimens of primary tumours in 175 patients with ESCC. Osteopontin was expressed in 48% of 175 patients. Osteopontin expression was significantly correlated with lymph node metastasis, lymphatic invasion, and stage (P=0.0015, 0.037 and 0.033, respectively). Tumours with expressing Osteopontin exhibited more lymph node metastasis, lymphatic invasion and advanced stage than the tumour with negative Osteopontin expression. Five-year survival rate was better in patients with negative Osteopontin expression than in those with positive Osteopontin expression (P=0.035). However, multivariate analysis revealed that Osteopontin expression was not an independent prognostic factor. As our findings suggest that Osteopontin may play an important role in progress of ESCC, the evaluation of Osteopontin expression is useful for predicting the malignant properties of ESCC

Topics: Molecular Diagnostics
OAI identifier: oai:pubmedcentral.nih.gov:2360684
Provided by: PubMed Central

Suggested articles

Citations

  1. (2005). Cancer Inst 94: 513–521 Al-Shami
  2. (2002). Osteopontin identified as lead marker of colon cancer progression, using pooled sample expression profiling.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.